Loading…
Quality of Life in Glaucoma: A Review of the Literature
The ultimate goal of glaucoma management is the preservation of patients’ visual function and quality of life (QoL). The disease itself as well as the medical or surgical treatment can have an enormous impact on a patient’s QoL. Even the mere diagnosis of a chronic, irreversible, potentially blindin...
Saved in:
Published in: | Advances in therapy 2016-06, Vol.33 (6), p.959-981 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c508t-df340ae1e829def80e2144f116ccc6101c7147b37a6345bd8f8e93ea49228c3c3 |
---|---|
cites | cdi_FETCH-LOGICAL-c508t-df340ae1e829def80e2144f116ccc6101c7147b37a6345bd8f8e93ea49228c3c3 |
container_end_page | 981 |
container_issue | 6 |
container_start_page | 959 |
container_title | Advances in therapy |
container_volume | 33 |
creator | Quaranta, Luciano Riva, Ivano Gerardi, Chiara Oddone, Francesco Floriano, Irene Konstas, Anastasios G. P. |
description | The ultimate goal of glaucoma management is the preservation of patients’ visual function and quality of life (QoL). The disease itself as well as the medical or surgical treatment can have an enormous impact on a patient’s QoL. Even the mere diagnosis of a chronic, irreversible, potentially blinding disorder can adversely affect the patient’s sense of well-being and QoL by eliciting significant anxiety. Patients with primary open-angle glaucoma rarely present with visual symptoms, at least early in the course of the disease. A better understanding of patient-reported QoL can improve patient–physician interaction and enhance treatment adherence by customizing treatment options based on individual patient profile, thus optimizing long-term prognosis. These aspects are summarized and critically appraised in this article. |
doi_str_mv | 10.1007/s12325-016-0333-6 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4920851</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1799559639</sourcerecordid><originalsourceid>FETCH-LOGICAL-c508t-df340ae1e829def80e2144f116ccc6101c7147b37a6345bd8f8e93ea49228c3c3</originalsourceid><addsrcrecordid>eNp9kEFLwzAUx4Mobk4_gBfp0Us1L2mT1IMwhk5hIIqCt5Blr1tH186knezbm9EpevHwyOH_e_8XfoScA70CSuW1B8ZZGlMQMeWcx-KA9EGJNA7DDkmfygRixtV7j5x4v6SUUZmqY9JjErgSNOkT-dyasmi2UZ1HkyLHqKiicWlaW6_MTTSMXnBT4OcubRYYiAadaVqHp-QoN6XHs_07IG_3d6-jh3jyNH4cDSexTalq4lnOE2oQULFshrmiyCBJcgBhrRVAwUpI5JRLI3iSTmcqV5hxNEnGmLLc8gG57XrX7XSFM4tV40yp165YGbfVtSn036QqFnpeb3RooCqFUHC5L3D1R4u-0avCWyxLU2Hdeg0yy9I0EzwLKHSodbX3DvOfM0D1TrjuhOsgXO-EaxF2Ln7_72fj23AAWAf4EFVzdHpZt64Kzv5p_QIpD4q9</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1799559639</pqid></control><display><type>article</type><title>Quality of Life in Glaucoma: A Review of the Literature</title><source>Springer Link</source><creator>Quaranta, Luciano ; Riva, Ivano ; Gerardi, Chiara ; Oddone, Francesco ; Floriano, Irene ; Konstas, Anastasios G. P.</creator><creatorcontrib>Quaranta, Luciano ; Riva, Ivano ; Gerardi, Chiara ; Oddone, Francesco ; Floriano, Irene ; Konstas, Anastasios G. P.</creatorcontrib><description>The ultimate goal of glaucoma management is the preservation of patients’ visual function and quality of life (QoL). The disease itself as well as the medical or surgical treatment can have an enormous impact on a patient’s QoL. Even the mere diagnosis of a chronic, irreversible, potentially blinding disorder can adversely affect the patient’s sense of well-being and QoL by eliciting significant anxiety. Patients with primary open-angle glaucoma rarely present with visual symptoms, at least early in the course of the disease. A better understanding of patient-reported QoL can improve patient–physician interaction and enhance treatment adherence by customizing treatment options based on individual patient profile, thus optimizing long-term prognosis. These aspects are summarized and critically appraised in this article.</description><identifier>ISSN: 0741-238X</identifier><identifier>EISSN: 1865-8652</identifier><identifier>DOI: 10.1007/s12325-016-0333-6</identifier><identifier>PMID: 27138604</identifier><language>eng</language><publisher>Cheshire: Springer Healthcare</publisher><subject>Cardiology ; Disease Management ; Endocrinology ; Glaucoma - diagnosis ; Glaucoma - psychology ; Glaucoma - therapy ; Health technology assessment ; Humans ; Internal Medicine ; Medicine ; Medicine & Public Health ; Oncology ; Patient Care Planning ; Pharmacology/Toxicology ; Prognosis ; Quality of Life ; Review ; Rheumatology ; Visual Field Tests</subject><ispartof>Advances in therapy, 2016-06, Vol.33 (6), p.959-981</ispartof><rights>The Author(s) 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c508t-df340ae1e829def80e2144f116ccc6101c7147b37a6345bd8f8e93ea49228c3c3</citedby><cites>FETCH-LOGICAL-c508t-df340ae1e829def80e2144f116ccc6101c7147b37a6345bd8f8e93ea49228c3c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27138604$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Quaranta, Luciano</creatorcontrib><creatorcontrib>Riva, Ivano</creatorcontrib><creatorcontrib>Gerardi, Chiara</creatorcontrib><creatorcontrib>Oddone, Francesco</creatorcontrib><creatorcontrib>Floriano, Irene</creatorcontrib><creatorcontrib>Konstas, Anastasios G. P.</creatorcontrib><title>Quality of Life in Glaucoma: A Review of the Literature</title><title>Advances in therapy</title><addtitle>Adv Ther</addtitle><addtitle>Adv Ther</addtitle><description>The ultimate goal of glaucoma management is the preservation of patients’ visual function and quality of life (QoL). The disease itself as well as the medical or surgical treatment can have an enormous impact on a patient’s QoL. Even the mere diagnosis of a chronic, irreversible, potentially blinding disorder can adversely affect the patient’s sense of well-being and QoL by eliciting significant anxiety. Patients with primary open-angle glaucoma rarely present with visual symptoms, at least early in the course of the disease. A better understanding of patient-reported QoL can improve patient–physician interaction and enhance treatment adherence by customizing treatment options based on individual patient profile, thus optimizing long-term prognosis. These aspects are summarized and critically appraised in this article.</description><subject>Cardiology</subject><subject>Disease Management</subject><subject>Endocrinology</subject><subject>Glaucoma - diagnosis</subject><subject>Glaucoma - psychology</subject><subject>Glaucoma - therapy</subject><subject>Health technology assessment</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Oncology</subject><subject>Patient Care Planning</subject><subject>Pharmacology/Toxicology</subject><subject>Prognosis</subject><subject>Quality of Life</subject><subject>Review</subject><subject>Rheumatology</subject><subject>Visual Field Tests</subject><issn>0741-238X</issn><issn>1865-8652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9kEFLwzAUx4Mobk4_gBfp0Us1L2mT1IMwhk5hIIqCt5Blr1tH186knezbm9EpevHwyOH_e_8XfoScA70CSuW1B8ZZGlMQMeWcx-KA9EGJNA7DDkmfygRixtV7j5x4v6SUUZmqY9JjErgSNOkT-dyasmi2UZ1HkyLHqKiicWlaW6_MTTSMXnBT4OcubRYYiAadaVqHp-QoN6XHs_07IG_3d6-jh3jyNH4cDSexTalq4lnOE2oQULFshrmiyCBJcgBhrRVAwUpI5JRLI3iSTmcqV5hxNEnGmLLc8gG57XrX7XSFM4tV40yp165YGbfVtSn036QqFnpeb3RooCqFUHC5L3D1R4u-0avCWyxLU2Hdeg0yy9I0EzwLKHSodbX3DvOfM0D1TrjuhOsgXO-EaxF2Ln7_72fj23AAWAf4EFVzdHpZt64Kzv5p_QIpD4q9</recordid><startdate>20160601</startdate><enddate>20160601</enddate><creator>Quaranta, Luciano</creator><creator>Riva, Ivano</creator><creator>Gerardi, Chiara</creator><creator>Oddone, Francesco</creator><creator>Floriano, Irene</creator><creator>Konstas, Anastasios G. P.</creator><general>Springer Healthcare</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160601</creationdate><title>Quality of Life in Glaucoma: A Review of the Literature</title><author>Quaranta, Luciano ; Riva, Ivano ; Gerardi, Chiara ; Oddone, Francesco ; Floriano, Irene ; Konstas, Anastasios G. P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c508t-df340ae1e829def80e2144f116ccc6101c7147b37a6345bd8f8e93ea49228c3c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Cardiology</topic><topic>Disease Management</topic><topic>Endocrinology</topic><topic>Glaucoma - diagnosis</topic><topic>Glaucoma - psychology</topic><topic>Glaucoma - therapy</topic><topic>Health technology assessment</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Oncology</topic><topic>Patient Care Planning</topic><topic>Pharmacology/Toxicology</topic><topic>Prognosis</topic><topic>Quality of Life</topic><topic>Review</topic><topic>Rheumatology</topic><topic>Visual Field Tests</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Quaranta, Luciano</creatorcontrib><creatorcontrib>Riva, Ivano</creatorcontrib><creatorcontrib>Gerardi, Chiara</creatorcontrib><creatorcontrib>Oddone, Francesco</creatorcontrib><creatorcontrib>Floriano, Irene</creatorcontrib><creatorcontrib>Konstas, Anastasios G. P.</creatorcontrib><collection>Springer_OA刊</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Advances in therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Quaranta, Luciano</au><au>Riva, Ivano</au><au>Gerardi, Chiara</au><au>Oddone, Francesco</au><au>Floriano, Irene</au><au>Konstas, Anastasios G. P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Quality of Life in Glaucoma: A Review of the Literature</atitle><jtitle>Advances in therapy</jtitle><stitle>Adv Ther</stitle><addtitle>Adv Ther</addtitle><date>2016-06-01</date><risdate>2016</risdate><volume>33</volume><issue>6</issue><spage>959</spage><epage>981</epage><pages>959-981</pages><issn>0741-238X</issn><eissn>1865-8652</eissn><abstract>The ultimate goal of glaucoma management is the preservation of patients’ visual function and quality of life (QoL). The disease itself as well as the medical or surgical treatment can have an enormous impact on a patient’s QoL. Even the mere diagnosis of a chronic, irreversible, potentially blinding disorder can adversely affect the patient’s sense of well-being and QoL by eliciting significant anxiety. Patients with primary open-angle glaucoma rarely present with visual symptoms, at least early in the course of the disease. A better understanding of patient-reported QoL can improve patient–physician interaction and enhance treatment adherence by customizing treatment options based on individual patient profile, thus optimizing long-term prognosis. These aspects are summarized and critically appraised in this article.</abstract><cop>Cheshire</cop><pub>Springer Healthcare</pub><pmid>27138604</pmid><doi>10.1007/s12325-016-0333-6</doi><tpages>23</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0741-238X |
ispartof | Advances in therapy, 2016-06, Vol.33 (6), p.959-981 |
issn | 0741-238X 1865-8652 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4920851 |
source | Springer Link |
subjects | Cardiology Disease Management Endocrinology Glaucoma - diagnosis Glaucoma - psychology Glaucoma - therapy Health technology assessment Humans Internal Medicine Medicine Medicine & Public Health Oncology Patient Care Planning Pharmacology/Toxicology Prognosis Quality of Life Review Rheumatology Visual Field Tests |
title | Quality of Life in Glaucoma: A Review of the Literature |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T05%3A43%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Quality%20of%20Life%20in%20Glaucoma:%20A%20Review%20of%20the%20Literature&rft.jtitle=Advances%20in%20therapy&rft.au=Quaranta,%20Luciano&rft.date=2016-06-01&rft.volume=33&rft.issue=6&rft.spage=959&rft.epage=981&rft.pages=959-981&rft.issn=0741-238X&rft.eissn=1865-8652&rft_id=info:doi/10.1007/s12325-016-0333-6&rft_dat=%3Cproquest_pubme%3E1799559639%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c508t-df340ae1e829def80e2144f116ccc6101c7147b37a6345bd8f8e93ea49228c3c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1799559639&rft_id=info:pmid/27138604&rfr_iscdi=true |